IRWD — IRONWOOD PHARMACEUTICALS INC

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1446847 ·
Last close
$4.87
Market Cap
$806.23M
52W High
$5.78
52W Low
$2.95
ADV30
2,303,760
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 — — — — — — —
Jun 2026 113,041,000 — 79,307,000 51,291,000 285,128,000 79,127,000 446,971,000
Mar 2026 106,506,000 — 72,533,000 40,773,000 434,566,000 220,471,000 651,710,000
Dec 2025 47,709,000 — 6,553,000 -2,276,000 396,901,000 215,456,000 658,736,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$185,555,000
Investing CF
$-1,000
Financing CF
$-199,575,000
CapEx
$-35,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.90
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-1,581,654,000
Inventory
—
Receivables
$112,732,000
ST Investments
—
EBIT TTM
$239,867,000
Pretax Income TTM
$207,378,000
Interest Exp TTM
$32,489,000
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$400,296,000
EBITDA
$253,560,000
Free Cash Flow
$121,834,752
Enterprise Value
$973,723,072
Total Cash
$86,376,000
Total Debt
$336,209,984
Shares Out
165,550,760
Trailing EPS
$0.90
Book Value
$-0.59
ROE
—
ROA
45.8%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 296,151,000 118,759,000 24,017,000 396,901,000 658,736,000 -261,835,000 127,044,000
Dec 2024 351,410,000 95,717,000 880,000 350,908,000 652,243,000 -301,335,000 103,549,000
Dec 2023 442,735,000 168,336,000 -1,002,239,000 471,073,000 817,368,000 -346,295,000 183,427,000
Dec 2022 410,596,000 250,337,000 175,065,000 1,100,519,000 448,141,000 652,378,000 273,763,000
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
$389,316,000
NetIncome TTM
$129,868,000
OpCashFlow TTM
—
Assets (Latest)
$285,128,000
Forward EPS
$1.50

Max Pain — expiry 2027-02-19

max pain strike: $2.50 · spot: $4.78 · call oi: 7,975 · put oi: 154
Expected Move to 2027-02-19: ±$1.40 (29.29%) — implied range $3.38 – $6.18 · ATM straddle on $5.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
RIGL RIGEL PHARMACEUTICALS INC $808.18M $42.92 —
ARDX ARDELYX, INC. $799.36M $3.18 —
COLL COLLEGIUM PHARMACEUTICAL, INC $793.98M $25.55 —
LXRX LEXICON PHARMACEUTICALS, INC. $792.52M $1.78 —
SNDX Syndax Pharmaceuticals Inc $828.26M $9.20 —

News headlines (Yahoo Finance, 1h cache)

Ironwood Pharmaceuticals Inc (IRWD) (Q3 2026) Earnings Call Highlights: Record LINZESS Sales ...
2026-11-06 01:14 · Yahoo
Ironwood (IRWD) Q3 2026 Earnings Call Transcript
2026-11-05 22:07 · Yahoo
What Ironwood Pharmaceuticals (IRWD) Said on Its Q3 Earnings Call
2026-11-05 21:14 · Yahoo
Ironwood Pharmaceuticals (IRWD) Beats Q3 Earnings Estimates
2026-11-05 13:35 · Yahoo
Ironwood: Q3 Earnings Snapshot
2026-11-05 12:15 · Yahoo
Ironwood Pharmaceuticals Raises Full-Year 2026 Financial Guidance Driven by Continued LINZESS U.S. Net Sales Growth and Strong Third Quarter Financial Performance
2026-11-05 12:05 · Yahoo
Ironwood Pharmaceuticals to Host Third Quarter 2026 Investor Update Call
2026-10-28 20:05 · Yahoo
Ironwood Pharmaceuticals Appoints Tammi Gaskins as Chief Executive Officer
2026-10-16 11:30 · Yahoo
Ironwood Pharmaceuticals to Participate in the Wells Fargo 21st Annual Healthcare Conference
2026-09-03 20:05 · Yahoo
Ironwood (IRWD) Q2 2026 Earnings Call Transcript
2026-08-13 17:43 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.